The present invention describes methods of treating cancer, cancer metastasis, and drug resistant cancers using miRNA inhibitors for example, inhibitors of miR-409-5p, miR-409-3p, miR-154*. Also described are methods of using the miRNA as biomarkers for example, to predict responsiveness to a cancer drug, to detect a disease state of cancer.